Ken Nakamura

Tokyo Medical Center, National Hospital Organization

Papers

2

Total Citations

9

H-Index

2

About

Ken Nakamura is a urologic surgeon and researcher whose work focuses on salvage treatments for recurrent prostate cancer following primary radiotherapy. His major contributions center on evaluating and refining whole-gland salvage strategies, particularly robot-assisted radical prostatectomy (RARP) and brachytherapy, for patients with locally recurrent disease after initial definitive radiation. In his 2016 case report, Nakamura published the first documented instance of salvage RARP following heavy ion radiotherapy (HIRT), demonstrating the feasibility of this approach in a 70-year-old patient. His 2019 case series further analyzed outcomes for patients undergoing either 125I brachytherapy or RARP as salvage therapy, providing critical comparative data on treatment efficacy and safety. While his citation counts remain modest (5 and 4 citations respectively), these works represent pioneering contributions to a niche but clinically important area—addressing the challenging management of radio-recurrent prostate cancer. Nakamura’s research is particularly valuable for surgeons and oncologists seeking evidence-based salvage options for patients with limited alternatives after failed primary radiotherapy.

Research Focus

Key Achievements

2
H-Index
2
Papers
9
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
The Initial Case Report: Salvage Robotic Assisted Radical Prostatectomy After Heavy Ion Radiotherapy
5 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Tokyo Medical Center, National Hospital Organization

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago